View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
August 2, 2010

Bioengineers Develop Long-Term Implantable Glucose Sensor

An implantable glucose sensor that continuously monitors tissue glucose and transmits data wirelessly has been developed by GlySens and the University of California, San Diego. The long-term glucose sensor could be used by patients with Type 1 or Type 2 diabetes to adjust the insulin dos

By cms admin

An implantable glucose sensor that continuously monitors tissue glucose and transmits data wirelessly has been developed by GlySens and the University of California, San Diego.

The long-term glucose sensor could be used by patients with Type 1 or Type 2 diabetes to adjust the insulin dose and timing of injections, reducing the risk of taking too much insulin and becoming hypoglycaemic.

UC San Diego Jacobs School of Engineering bioengineering professor Gough said that if insulin pumps were programmed based on near real-time readings from implanted glucose sensors, the pumps would adjust insulin dosing accordingly.

“With an insulin pump, there is always the concern that it will pump too much insulin, leading to dangerously low blood glucose levels. The sensor could serve as a safety mechanism against low blood glucose levels,” said Gough.

Bioengineers in the US have successfully tested the sensor in animals and are planning to begin the first human trial within a few months.

The device is a potential alternative to finger sticking and short-term needle-like glucose sensors that have to be replaced every three to seven days.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management